CTVTs usually spontaneously regress (the SR phase) after progressive growth (the P phase), during which the tumours secrete a high concentration of TGF-β, which suppresses the expression of MHC class I and II molecules in tumours [8]. Here, TGFB1 is linked to neoplasm.